Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Item
http://www.wikidata.org/entity/Q36073613
Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherenceFactors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysisGRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.Gender- and age-related treatment compliance in patients with osteoporosis in Germany.Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice.Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary.Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and SlovakiaPersistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
P2860

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Item
http://www.wikidata.org/entity/Q36073613
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Persistence, adherence, and me ...... opean non-interventional study
@ast
Persistence, adherence, and me ...... opean non-interventional study
@en
type
label
Persistence, adherence, and me ...... opean non-interventional study
@ast
Persistence, adherence, and me ...... opean non-interventional study
@en
prefLabel
Persistence, adherence, and me ...... opean non-interventional study
@ast
Persistence, adherence, and me ...... opean non-interventional study
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Persistence, adherence, and me ...... opean non-interventional study
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932